Illustrative

Weight-Loss Drugs Could Cost Just $3 a Month to Make as Patents End

ScienceAlert·Mar 9

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A study has found that certain weight-loss drugs, including Ozempic and Wegovy, could be made for as little as $3 a month. The affordability of these medications is expected to increase as patents end, potentially leading to the availability of generic versions. The exact implications for patients and the timeline for generic availability are still unclear.

Full coverage

Weight-loss jab could be made for $3 a month, study finds

The Guardian·Mar 6

Novo Nordisk's Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds

STAT·Mar 6

Ozempic knockoffs could cost less than $3: study (NVO:NYSE)

Seeking Alpha·Mar 6

Generic Ozempic Could Cost Less Than $3 a Month, Study Shows

Bloomberg.com·Mar 6

Ozempic’s Active Ingredient Could Cost Just $3 a Month to Make – The Real Story Starts When Patents End

NCHStats·Mar 9

Ozempic Is About to Go Generic for Billions of People

The New York Times·Mar 30

Weight-loss drug Wegovy to be available in pill form in UK for first time

BBC·Jun 11

Ozempic's Key Ingredient Could Be Produced for Just $3 a Month. What Does That Mean for Patients?

inc.com·Mar 6

View original report at ScienceAlert ↗

Fetching the latest headlines…